Suzetrigine in Total Hip Arthroplasty

Clinical trial NCT07226700 · RECRUITING

Trial details

NCT number: NCT07226700
Sponsor: Hospital for Special Surgery, New York
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Total Hip Arthroplasty (THA)Total Hip Arthroplasty \(THA\)Total Hip Replacement Total Hip Replacement Surgery Total Hip Replacements Total Hip Replacement Arthroplasty Suzetrigine Pain Management Pain Nav 1.8 JOURNAVX Opioid Cessation

Start date: 2025-11-03
Primary completion: 2027-11-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.